Skip to content

Two Methods of Diagnosing Preterm Labor

Randomized Controlled Trial of Two Methods of Diagnosing Preterm Labor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01431885
Enrollment
82
Registered
2011-09-12
Start date
2011-08-31
Completion date
2015-02-13
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Delivery, Preterm Labor

Keywords

fibronectin, cervical length

Brief summary

Use of modern diagnostic tools e.g. fetal fibronectin and ultrasound measurement of cervical length to diagnose preterm labor can result in improved outcomes compared to traditional diagnosis based on digital examination to measure cervical change.

Detailed description

Symptomatic preterm labor patients will be randomized to diagnosis of preterm labor by serial digital examination versus an algorithm incorporating transvaginal ultrasound measurement of cervical length and vaginal fetal fibronectin.

Interventions

PROCEDUREDiagnosis by cervical length and fibronectin

Diagnosis will be made by MOD Algorithm B

PROCEDURECervical change

Diagnosis will be made by digital examination of cervical change

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* symptomatic complaints suggestive of preterm labor * greater than 6 contractions per hour

Exclusion criteria

* multiple gestation * rupture of amniotic membranes * chorioamnionitis * congenital malformations * persistent vaginal bleeding * abruptio placentae * placenta previa * previously diagnosed short cervix \< 2.5 cm * cervical dilation \> 3 cm * cervical cerclage * exposure to tocolytic drugs * allergy or contraindication to nifedipine

Design outcomes

Primary

MeasureTime frameDescription
Delivery prior to 37 weeks' gestationNo longer than 18 weeks post randomization (at which time a pregnancy randomized at the earliest possible gestational age would be 42 weeks, generally the contemporary upper limit of the duration of pregnancy)Delivery of the baby prior to 37 weeks' gestation by any means and for any reason including spontaneous or indicated delivery for maternal or fetal complications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026